Table 1.
Hormonal and biochemical evaluation of patient throughout hospitalization and follow-up.
| Normal range | On hospital admission | After surgery | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 10 days | 2 months | 3 months | 6 months | 9 months | 12 months | 16 months | |||
| ACTH (pg/mL) | 9–52 | 551 | 7 | 37 | 50 | 29.5 | 26 | 40.9 | 52 |
| Morning cortisol† (µg/dL) | 7–19.2 | 63.4 | 14 | 5.1 | 3.5 | 3.8 | 4.2 | 7.2 | 12.8 |
| After 1 mg overnight dexamethasone | |||||||||
| ACTH | 583 | ||||||||
| Cortisol | 60 | ||||||||
| DHEAS (µg/dL) | 9.4–246 | 201 | |||||||
| 24-h urinalysis (µg/24 h) | |||||||||
| Adrenaline | 0–14.9 | 95.5 | |||||||
| Noradrenaline | 0–66 | 1133 | |||||||
| Metanephrine | 74–297 | 1927 | |||||||
| Normetanephrine | 105–354 | 1133 | |||||||
| Chromogranin A | 0–108 | 290 | |||||||
| Renin (supine) (µU/mL) | 2.4–29 | 3.9 | 14.6 | ||||||
| Aldosterone (supine) (ng/dL) | 3–15 | 3.4 | 12.5 | ||||||
| LH (mIU/mL)* | > 10 | 0.3 | 65.8 | ||||||
| FSH (mIU/mL)* | > 25 | 1.9 | 116 | ||||||
| PRL (ng/mL) | 3–24 | 13.7 | |||||||
| FT4 (ng/dL) | 0.9–1.7 | 1.1 | 1.2 | ||||||
| FT3 (pg/mL) | 1.8–4.6 | 1.1 | 2.7 | ||||||
| TSH (µU/mL) | 0.27–4.2 | 0.23 | 1.3 | ||||||
| PTH (pg/mL) | 15–65 | 166 | |||||||
| Calcium (mg/dL) | 8.2–10.2 | 8.2 | |||||||
| Calcitonin (pg/mL) | 0–10 | 1 | |||||||
| Glycaemia (mg/dL) | 60–110 | 212 | 69 | 73 | 83 | ||||
| Potassium (mEq/L) | 3.5–5 | 2.4 | 3.3 | 3.9 | 4.2 | 3.7 | 5 | 4.4 | 3.9 |
| Leucocytes (K/µL) | 4.0–9.3 | 15.13 | |||||||
| HbA1c (mmol/mol) | 20–42 | 55 | 30 | ||||||
| HCO3− (mEq/L) | 22–26 | 41.8 | |||||||
*For menopausal age; †07:00–10:00 h.
This work is licensed under a